[1] Zhao Z, Zhou K, Liu B.  Added value of SPECT/CT in the evaluation of sacral fracture in patients with lung cancer[J]. Clin Nucl Med, 2018, 43(6): e195-e197.   doi: 10.1097/RLU.0000000000002082
[2] 中华医学会核医学分会.  2018年全国核医学现状普查结果简报[J]. 中华核医学与分子影像杂志, 2018, 38(12): 813-814.   doi: 10.3760/cma.j.issn.2095-2848.2018.12.010
Chinese Society of Nuclear Medicine.  A brief report on the results of the national survey of nuclear medicine in 2018[J]. Chin J Nucl Med Mol Imaging, 2018, 38(12): 813-814.   doi: 10.3760/cma.j.issn.2095-2848.2018.12.010
[3] Hauptmann M, Daniels RD, Cardis E, et al.  Epidemiological studies of low-dose ionizing radiation and cancer: summary bias assessment and meta-analysis[J]. J Natl Cancer Inst Monogr, 2020, 2020(56): 188-200.   doi: 10.1093/jncimonographs/lgaa010
[4] Little MP, Kitahara CM, Cahoon EK, et al.  Occupational radiation exposure and risk of cataract incidence in a cohort of US radiologic technologists[J]. Eur J Epidemiol, 2018, 33(12): 1179-1191.   doi: 10.1007/s10654-018-0435-3
[5] Bernier MO, Journy N, Villoing D, et al.  Cataract risk in a cohort of U. S. radiologic technologists performing nuclear medicine procedures[J]. Radiology, 2018, 286(2): 592-601.   doi: 10.1148/radiol.2017170683
[6] Jin P, Feng HJ, Ouyang W, et al.  Radiation dose rates of differentiated thyroid cancer patients after 131I therapy[J]. Radiat Environ Biophys, 2018, 57(2): 169-177.   doi: 10.1007/s00411-018-0736-7
[7]

Han S, Jin S, Yoo SH, et al. A practical individualized radiation precaution based on the dose rate at release time after inpatient 131I ablation therapy[J/OL]. PLoS One, 2021, 16(5): e0251627[2020-09-13]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0251627. DOI: 10.1371/journal.pone.0251627.
[8]

Stachura A, Gryn T, Kałuża B, et al. Predictors of euthyreosis in hyperthyroid patients treated with radioiodine 131I: a retrospective study[J/OL]. BMC Endocr Disord, 2020, 20(1): 77[2020-09-13]. https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-020-00551-2.  DOI: 10.1186/s12902-020-00551-2.
[9]

National Council on Radiation Protection and Measurements. NCRP report No. 155-management of radionuclide therapy patients(2006)[R]. Bethesda: National Council on Radiation Protection and Measurements, 2006.
[10] Mattsson S, Johansson L, Leide Svegborn S, et al.  Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances[J]. Ann ICRP, 2015, 44(S2): S7-321.   doi: 10.1177/0146645314558019
[11] López PO, Dauer LT, Loose R, et al.  ICRP publication 139: occupational radiological protection in interventional procedures[J]. Ann ICRP, 2018, 47(2): 1-118.   doi: 10.1177/0146645317750356
[12] Foreman C, Dewji S.  Estimation of external dose rates to hotel workers from bed linens contaminated by 131I patients[J]. Health Phys, 2020, 118(6): 615-622.   doi: 10.1097/HP.0000000000001141
[13] Stabin MG, Siegel JA.  RADAR dose estimate report: a compendium of radiopharmaceutical dose estimates based on OLINDA/EXM version 2.0[J]. J Nucl Med, 2018, 59(1): 154-160.   doi: 10.2967/jnumed.117.196261